Core Viewpoint - The China Securities Index for Hong Kong Stock Connect Medical Devices shows a recent decline, but has experienced significant growth over the past three months and year-to-date [1]. Group 1: Index Performance - The China Securities Index for Hong Kong Stock Connect Medical Devices reported a recent value of 1194.94 points [1]. - Over the past month, the index has decreased by 3.48%, while it has increased by 15.43% over the last three months and 12.63% year-to-date [1]. Group 2: Index Composition - The index is composed entirely of securities listed on the Hong Kong Stock Exchange, with a sample that includes various sectors classified under the China Securities Industry Classification Standard [2]. - The index's sample shows that medical consumables account for 79.10%, medical devices for 16.57%, and in vitro diagnostics for 4.34% [2]. Group 3: Index Adjustments - The index samples are adjusted biannually, specifically on the second Friday of June and December, with weight factors fixed until the next scheduled adjustment [2]. - In cases of special events affecting the index sample, such as delisting or mergers, adjustments will be made accordingly [2].

Group 1 - The core viewpoint of the article highlights the performance of the CSI Hong Kong-Shanghai Biotech Theme Index, which reflects the overall performance of listed companies in the biotech sector from mainland China and Hong Kong [1][3] - The CSI Hong Kong-Shanghai Biotech Theme Index has shown an increase of 0.82% over the past month, 12.93% over the past three months, and 12.21% year-to-date [1] - The index consists of 50 sample companies involved in biopharmaceuticals, pharmaceuticals, and biotech services, with a base date of December 28, 2018, set at 1000.0 points [1] Group 2 - The top ten weighted companies in the index include: Heng Rui Medicine (13.16%), BeiGene (10.43%), WuXi AppTec (8.41%), Mindray Medical (7.71%), WuXi Biologics (5.15%), Innovent Biologics (4.82%), CanSino Biologics (3.91%), Shanghai Pharmaceuticals (2.74%), China National Pharmaceutical Group (2.45%), and Shanghai RAAS Blood Products (1.83%) [1] - The market share of the index holdings is distributed as follows: Hong Kong Stock Exchange 41.72%, Shanghai Stock Exchange 35.62%, and Shenzhen Stock Exchange 22.66% [1] Group 3 - In terms of industry composition, biopharmaceuticals account for 43.26%, chemical drugs for 25.78%, pharmaceutical and biotech services for 21.39%, and medical devices for 9.57% [2] - The index samples are adjusted semi-annually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2] - Special circumstances may lead to temporary adjustments to the index, including the removal of samples that are delisted or changes due to mergers, acquisitions, or other corporate actions [2]

4月28日消息，港股三大指数震荡调整，截至收盘，恒生指数跌0.04%，报21971.96点，恒生科技指数涨 0.12%，国企指数平收。盘面上，科网股涨跌不一，京东集团涨超2%，美团涨超0.5%，联想集团跌超 1%，百度集团、网易跌近1%；内银股走强，盛京银行涨超8%；核电股普涨，中广核电力涨超2%；耀 才证券金融一度涨逾96%。 | 02066 | 廠京银行 | 1.060 | 8.16% | | --- | --- | --- | --- | | 03866 | 青岛银行 | 3.560 | 7.23% | | 01963 | 重庆银行 | 7.500 | 5.78% | | 01916 | 江西银行 | 0.790 | 5.33% | | 06818 | 中国光大银行 | 3.400 | 4.29% | | 01578 | 天津银行 | 1.820 | 3.41% | | 03618 | 重庆农村商业银行 | 5.990 | 2.92% | | 01288 | 农业银行 | 4.840 | 2.76% | | 06138 | 哈尔滨银行 | 0.295 | 1.72% | | 02388 | 楔根器 | ...

截至4月28日收盘，安乐工程（01977.HK）报0.750港元，较上个交易日上涨2.74%，当日盘中最低价触 及0.720港元，创近一年新低。 本文源自：金融界 资金流向方面，当日主力流入3.848万港元，流出19.818万港元，净流出15.97万港元。 作者：港股君 安乐工程集团有限公司(以及其附属公司)('安乐工程'或'本集团')成立于1977年,是一家主要的电气和机械 工程和技术服务提供商,总部设在香港,在澳门、中国大陆、美国和联合王国开展业务。本集团为来自公 营及私营机构的广大客户提供多元及全面的电子工程及科技服务,包括建筑服务、环境工程、资讯、通 讯及建筑科技及升降机及自动梯。公司的母公司模拟控股有限公司于1995年成立,并于2019年在香港证 券交易所的主董事会上市(股票代码:1977)。公司的一些项目:港珠澳大桥工程服务。香港第一个有机资 源回收中心。昂船洲是世界上最大的化学强化初级废水处理厂之一,为香港提供经过加工和处理的水。 香港国际机场是世界上最好的机场之一,这是一个创新的过境生物鉴别系统。香港科学园的智能建筑,新 创意和创新需要最好的建筑系统。香港中央至中层的自动扶梯及人行道系统的翻新 ...

智通财经4月28日电，香港交易所信息显示，贝莱德在哔哩哔哩-W的持股比例于04月22日从5.05%降至 4.79%。 ...

去年营收166.57亿元，业务保持稳健发展，现金流充沛，在手订单充足。这就是神州控股(00861.HK)最 新交给市场的成绩单。 记者从公司处获悉，神州控股将于4月29日至30日第八届数字中国建设峰会期间，联合北京交通大学、 中国数联物流信息有限公司、中国星网数字科技有限公司，于4月30日共同举办"数字交通与物流分论 坛"，分享物流信息开放互联研究和实践经验，共促物流行业数智化转型，助推数字经济高质量发展。 面对AI技术革命，神州控股以"技术+场景+生态"模式抢占市场，在多个业务领域形成了可复制的典型 案例。依托国家技术发明奖一等奖成果转发的燕云DaaS进一步升级迭代为燕云Infinity，成为驱动公司 业务发展的核心引擎，也正在成为数据要素价值释放的工具。 在推进AI技术的场景化落地方面，公司在食品龙头企业打造的供应链控制塔，助力客户风险预警提示 项超90%，发货效率提升超20%、场内物流效率增幅超20%、成本节约超5%、耗材用量减少65%。 今年3月，神州控股旗下的神旗数码基于自身核心技术推出了融合DeepSeek私有化部署的端到端一体化 数据智能解决方案，助力客户打造AI好帮手，让客户在能够保持活跃能力 ...

智通财经APP获悉，4月28日，现制茶饮品牌沪上阿姨(02589)正式开启招股，至5月2日结束，拟全球发 售241.134万股H股，其中香港发售占10%，国际发售占90%，另有超额配股权不超过15%;发售价将不高 于每股发售股份113.12港元，且预期不低于每股发售股份95.57港元;每手30股，预期将于5月8日上午九 时正开始在联交所买卖。 财务数据方面，沪上阿姨同样亮眼。2022年-2024年，公司的营收分别为21.99亿元、33.48亿元和32.85 亿元;经调整净利润则分别为1.54亿元、4.16亿元和4.18亿元，整体势头强劲。 近期新茶饮赛道火热，头部品牌纷纷加速布局。此前业内人士分析提到，早前奈雪的茶、茶百道相继登 陆资本市场。今年以来，古茗、蜜雪冰城、霸王茶姬三家新茶饮品牌成功上市，给行业注入"强心剂"， 其中，蜜雪冰城更是创下港股IPO冻资新纪录，上市后股价一路飙升。霸王茶姬赴美上市成功后，新茶 饮赛道更是赚足了一波眼球。 此次招股，沪上阿姨引入2名基石投资者，合共认购约921.55万美元的发售股份，其中盈峰控股认购约 644.04万美元、华宝股份认购约277.51万美元。此次IPO，沪上阿 ...

李宁：一季度销售点（不包括李宁YOUNG）于整个平台之零售流水按年录得低单位数增长。 ...

资金流向方面，当日主力流入179808.742万港元，流出145284.198万港元，净流入34524.54万港元。 耀才证券金融集团有限公司于1995年在香港创立,2010年于联交所主板上市(耀才证券金融集团有限公司, 香港股份代号:01428),为客户提供全面而专业的经纪服务,业务涵盖港股、美股、英股、日股、台股、新 加坡股、澳股、沪港通A股、深港通A股、中国B股、恒生指数期货、恒生指数期权、港股期权、道指 期货、A50期货、外汇期货、期金、期油及期铜、杠杆式外汇产品、人民币(香港)黄金期货、美元(香 港)黄金期货、铁矿石期货、新股认购以及股票融资等等。开业至今,凭借网上交易平台稳定及落盘速度 惊人,一直领先同行;加上其特低佣金、股票融资比率特高、融资利息特低,深受客户欢迎。现时公司拥有 员工接近300名,并设有14个营业点,遍布香港、九龙及新界。本公司宗旨为「以客为先、服务第一」,致 力提供「快餐厅收费,六星级服务」的证券及期货交易服务。自2003年香港政府取消「最低佣金制度」 后,本公司随即率先由原来0.25%的佣金收费大幅调低至0.05%,此后客户人数迅速增长,于2006年晋身联交 所B组参与者(按 ...

Core Insights - The company reported a strong revenue growth of 24.4% year-on-year, reaching RMB 57.65 billion for the first quarter of 2025, despite challenges such as a slight slowdown in natural gas consumption and the impact of the Chinese New Year holiday [1][2] Group 1: Clean Energy Division - The clean energy division achieved a significant revenue increase of 33.4% year-on-year, amounting to RMB 43.42 billion, making it the largest contributor to the company's overall revenue at 75.3% [2] - Hydrogen energy revenue within the clean energy division was approximately RMB 1.43 billion [2] - The clean energy division secured new orders totaling RMB 38.58 billion, although the Chinese New Year holiday affected the completion of several project bids [1] Group 2: Chemical Environment Division - The chemical environment division reported a revenue of RMB 5.70 billion, a slight increase of 1.4% year-on-year, contributing 9.9% to the overall revenue [2] - New orders in the chemical environment division reached RMB 4.44 billion, reflecting a year-on-year growth of 17.3% [1][2] - Revenue from high-end medical equipment components within this division grew by 21.0% to RMB 54.41 million [2] Group 3: Liquid Food Division - The liquid food division's revenue increased by 4.3% year-on-year to RMB 8.53 billion, accounting for 14.8% of the total revenue [2] - The division is actively pursuing several large industrial beer projects in North America and the Middle East [1] - The company's production base in Mexico commenced full operations at the beginning of 2025, enhancing its global capabilities in liquid food turnkey projects [2]